According to the new market research report “Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) – Global Forecast to 2024” published by MarketsandMarkets™.The Pen Needles Market is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period.Recent Developments in Insulin Pen Needles Market:In 2018, Becton, Dickinson and Company (US) launched its BD Ultra-Fine micro pen needle 6mm x 32G in the market.In 2016, Ypsomed (Switzerland) entered into an agreement with Tonghua Dongbao Pharmaceutical (China) with an aim to distribute its mylife Clickfine pen needles in China.In 2015, Ypsomed (Switzerland) launched mylife Clickfine DiamondTip pen needles.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613The standard pen needles segment held the largest share of the market in 2018Based on type, the market is segmented into standard and safety pen needles.
In 2018, the standard pen needles segment accounted for the largest share of the pen needles market.
The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil where the presence of safety pen needles is very low to negligible.
However, as standard needles are not equipped with safety shields, the risk of accidental needlestick injuries (NSIs) with the use of these needles is high.Geographical Regions Mapped in Report:North America dominated the pen needles market in 2018.
For instance, Ypsomed Holding AG (Switzerland) has launched mylife Clickfine DiamondTip pen needles with the innovative 6-bevel technology, and Becton, Dickinson and Company (US) has upgraded its pen needles with the PentaPoint and Easy Flow technologyDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613Key Market Players;The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK).Becton, Dickinson and Company (US) dominated the pen needles market in 2018.
The company offers a wide range of drug delivery products.